ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : sequence alignment
Scheme : NHMRC Project Grants
Clear All
Filter by Field of Research
Medical and Health Sciences (2)
Biochemistry And Cell Biology Not Elsewhere Classified (1)
Cancer Genetics (1)
Genetic Development (Incl. Sex Determination) (1)
Medical Genetics (1)
Medical Microbiology not elsewhere classified (1)
Oncology And Carcinogenesis (1)
Other biomedical and clinical sciences not elsewhere classified (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (14)
Filter by Status
Closed (14)
Filter by Scheme
NHMRC Project Grants (14)
Filter by Country
Search did not return any results.
Filter by Australian State/Territory
Search did not return any results.
  • Researchers (0)
  • Funded Activities (14)
  • Organisations (11)
  • Funded Activity

    Studies On Mosquito-transmitted Viruses Of Medical Impo Rtance In Australia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $329,773.00
    More information
    Funded Activity

    Functional Evaluation Of BRCA1 & BRCA2 Unclassified Sequence Variants And Identification Of Critical Pathogenic Domains.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $331,312.00
    Summary
    The major genes that predispose to hereditary breast cancer are called BRCA1 and BRCA2. Most mutations in these genes cause the protein product to be truncated and inactive. However there are many families in which such truncating mutations are not found, but instead there are sequence changes that slightly alter the protein product. It is often difficult to predict whether these sequence variants are likely to cause hereditary breast cancer simply by looking at the position and nature of the se .... The major genes that predispose to hereditary breast cancer are called BRCA1 and BRCA2. Most mutations in these genes cause the protein product to be truncated and inactive. However there are many families in which such truncating mutations are not found, but instead there are sequence changes that slightly alter the protein product. It is often difficult to predict whether these sequence variants are likely to cause hereditary breast cancer simply by looking at the position and nature of the sequence change. Consequently, it is not possible to offer informative genetic counselling to these women or their at-risk family members. Assessment of the potential pathogenicity and functional significance of these unclassified sequence variants will be directly useful with regard to the clinical management of these women and their families, and will develop our current understanding of how different domains of these genes contribute to their role as cancer susceptibility genes.
    Read more Read less
    More information
    Funded Activity

    Genomic Prospecting For Disease Genes: Application Of The Ancestral Sequence

    Funder
    National Health and Medical Research Council
    Funding Amount
    $302,317.00
    More information
    Funded Activity

    Evaluation Of Unclassified Variants Of BRCA1 And BRCA2 Using A Multifactorial Approach

    Funder
    National Health and Medical Research Council
    Funding Amount
    $456,495.00
    Summary
    The major genes that predispose to hereditary breast cancer are called BRCA1 and BRCA2. Most mutations in these genes cause the protein product to be truncated and inactive. However there are many families in which such truncating mutations are not found, but instead there are sequence changes that may slightly alter the protein product. It is often difficult to predict whether these sequence variants are likely to cause hereditary breast cancer simply by looking at the position and nature of th .... The major genes that predispose to hereditary breast cancer are called BRCA1 and BRCA2. Most mutations in these genes cause the protein product to be truncated and inactive. However there are many families in which such truncating mutations are not found, but instead there are sequence changes that may slightly alter the protein product. It is often difficult to predict whether these sequence variants are likely to cause hereditary breast cancer simply by looking at the position and nature of the sequence change. Consequently, it is not possible to offer informative genetic counselling to these women or their at-risk family members. Assessment of the potential pathogenicity and functional significance of these unclassified sequence variants will be directly useful with regard to the clinical management of these women and their families, and will develop our current understanding of how different domains of these genes contribute to their role as cancer susceptibility genes. In addition, some of our experiments to classify variants may be useful as a screening tool to identify carriers of mutations, and so prioritize them for mutation screening.
    Read more Read less
    More information
    Funded Activity

    The Influence Of Chromatin Structure On Cisplatin-induced DNA Damage

    Funder
    National Health and Medical Research Council
    Funding Amount
    $182,911.00
    More information
    Funded Activity

    Investigations Of Virus Factors Influencing The Behavio Ur Of Cervical Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $142,525.00
    More information
    Funded Activity

    Search For Active Components For A Malaria Vaccine

    Funder
    National Health and Medical Research Council
    Funding Amount
    $303,810.00
    More information
    Funded Activity

    A New Method To Determine DNA Sequences Damaged By The Anti-tumour Agent Cisplatin

    Funder
    National Health and Medical Research Council
    Funding Amount
    $122,341.00
    More information
    Funded Activity

    Relation Between A Protein Active In Cell Division And A Tumour Growth Factor

    Funder
    National Health and Medical Research Council
    Funding Amount
    $90,991.00
    More information
    Funded Activity

    A Trial Of Prehospital Rapid Sequence Intubation In Patients With Severe Head Injury

    Funder
    National Health and Medical Research Council
    Funding Amount
    $311,000.00
    Summary
    In Australia, major trauma is a leading cause of death in people between the ages of one and 44 years. In addition to mortality, there is a high morbidity rate and quality adjusted life-years lost from injury is vast. In broad terms, major trauma is defined as those injuries with the highest severity, requiring time critical medical care. Over 10% of major trauma patients have a severe head injury and approximately 40% of these patients die and another 40% have significant long-term morbidity. F .... In Australia, major trauma is a leading cause of death in people between the ages of one and 44 years. In addition to mortality, there is a high morbidity rate and quality adjusted life-years lost from injury is vast. In broad terms, major trauma is defined as those injuries with the highest severity, requiring time critical medical care. Over 10% of major trauma patients have a severe head injury and approximately 40% of these patients die and another 40% have significant long-term morbidity. Following severe head injury, it is common for patients to have decreased oxygen levels and this is associated with a significant increase in brain damage. To prevent or treat this, patients with severe head injury require endotracheal intubation (a tube is placed in the airway to provide oxygen to the patient) as soon as possible following injury. However, in most patients with severe head injury, endotracheal intubation requires the use of drugs to facilitate placement of the endotracheal tube. The usual technique involves the administration of both a sedative drug and an appropriate muscle-relaxant. This technique is known as rapid sequence intubation (RSI). However, it is unknown whether RSI should be undertaken by paramedics early after injury or be delayed until arrival at the hospital. Since better evidence of improved outcome is required to justify the possible risk and considerable expense of training ambulance paramedics in the skill of RSI, it is proposed that a randomized, controlled trial of RSI in adults with severe head injury be conducted. This trial will compare rapid sequence intubation with standard airway management (no intubation) by ambulance paramedics for major trauma patients with severe head injury. This study will assess differences in patient outcome at 6-months post injury. The study will involve head injury patients treated by paramedics in Victoria.
    Read more Read less
    More information

    Showing 1-10 of 14 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback